Tyche Industries Share Price | Tyche Industries Stock Screener
TYCHE
Pharmaceuticals
Share Price BSE
₹125.55
▼
-1.10 (-0.87%)
As of July 6, 2026, the Tyche Industries share price (BSE: TYCHE) is ₹125.55, down 0.87% from the previous close, with shares trading between ₹125.00 and ₹128.90, and a 52-week range of ₹99.80–₹145.80.
Analyse TYCHE price trends and track historical price performance.
Use the Tyche Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Tyche Industries Market Cap
₹128.11 Cr.
TYCHE P/E Ratio (TTM)
18.71
Tyche Industries P/B Ratio
0.92
EPS (TTM)
₹6.70
Dividend Yield
2.76%
Debt to Equity
-
TYCHE 52 Week High
₹145.80
Tyche Industries 52 Week Low
₹99.80
Operating Margin
4.00%
Profit Margin
12.96%
TYCHE Revenue (TTM)
₹54.00
EBITDA
₹2.00
Net Income
₹7.00
Total Assets
₹148.00
Total Equity
₹141.00
Tyche Industries Share Price Chart
Screen Tyche Industries share price with an interactive chart. Analyse TYCHE price trends and volatility across different timeframes.
Tyche Industries Company Profile - Fundamental Screener
Screen Tyche Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for TYCHE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE443B01012
Tyche Industries Balance Sheet Screener
Screen TYCHE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 148 | 147 | 135 | 137 | 120 | 117 | 95 | 74 | 67 | 61 |
| Current Assets | 108 | 121 | 113 | 112 | 101 | 96 | 75 | 53 | 45 | 32 |
| Fixed Assets | 19 | 17 | 18 | 17 | 17 | 18 | 18 | 19 | 20 | 27 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 141 | 137 | 127 | 117 | 104 | 96 | 77 | 60 | 53 | 48 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | 130 | 127 | 117 | 107 | 94 | 86 | 67 | 50 | 43 | 38 |
Tyche Industries Income Statement Screener - Profit & Revenue Analysis
Screen Tyche Industries income statement and profit fundamentals.
Analyze TYCHE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Tyche Industries share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54 | 73 | 75 | 80 | 66 | 83 | 77 | 57 | 53 | 45 | 56 | 64 |
| Expenses | 51 | 54 | 57 | 59 | 51 | 54 | 52 | 45 | 43 | 37 | 51 | 57 |
| EBITDA | 2 | 19 | 19 | 21 | 15 | 30 | 25 | 12 | 11 | 8 | 5 | 7 |
| Operating Profit % | 4.00% | 17.00% | 18.00% | 21.00% | 18.00% | 32.00% | 29.00% | 17.00% | 18.00% | 14.00% | 5.00% | 11.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit Before Tax | 9 | 17 | 17 | 19 | 13 | 27 | 23 | 10 | 9 | 6 | 3 | 3 |
| Tax | 3 | 4 | 4 | 5 | 3 | 7 | 6 | 3 | 3 | 3 | 0 | 1 |
| Net Profit | 7 | 12 | 12 | 14 | 9 | 20 | 18 | 7 | 6 | 3 | 3 | 2 |
| EPS | 6.70 | 12.20 | 11.78 | 13.74 | 9.18 | 19.35 | 17.14 | 6.97 | 5.72 | 3.02 | 2.42 | 1.89 |
Tyche Industries Cash Flow Screener - Liquidity Fundamentals
Screen TYCHE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 9 | 8 | 6 | 5 | 15 | 15 | 4 | 5 | 11 | 12 |
| Investing Activities | -1 | 4 | -3 | 3 | 0 | 2 | 1 | 6 | 1 | -1 |
| Financing Activities | -3 | -2 | -2 | -1 | -1 | -1 | 0 | -1 | -11 | 2 |
| Net Cash Flow | 5 | 10 | 2 | 7 | 15 | 17 | 4 | 11 | 1 | 12 |
Tyche Industries Shareholding Pattern Screener
See Tyche Industries shareholding pattern with promoter, FII, and DII holdings.
Check Tyche Industries promoter holding and ownership changes for TYCHE on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 61.97% | 61.97% | 61.97% | 62.05% | 61.97% | 61.97% | 61.97% | 61.97% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 26.55% | 26.91% | 26.76% | 26.57% | 26.51% | 27.80% | 27.58% | 27.80% |
| Other Holding | 11.48% | 11.13% | 11.27% | 11.38% | 11.52% | 10.23% | 10.45% | 10.23% |
| Shareholder Count | 6,952 | 7,425 | 7,376 | 7,257 | 7,152 | 7,867 | 7,477 | 7,264 |
Tyche Industries Share Dividend Screener - Share Yield Analysis
Check Tyche Industries dividend history with payout and yield data.
View Tyche Industries dividend details including ex-dates and amounts for TYCHE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹3.00 | 3.01% |
| 2024-March | ₹2.50 | 1.88% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.50 | 1.09% |
| 2021-March | ₹1.00 | 0.72% |
| 2020-March | ₹1.00 | 0.59% |
| 2019-March | ₹0.50 | 0.67% |
| 2018-March | ₹0.50 | 0.72% |
| 2017-March | ₹0.50 | 0.47% |
Tyche Industries Stock Index Membership
See which indices include Tyche Industries stock.
Check TYCHE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Tyche Industries Market Events Screener - Corporate Actions
Get Tyche Industries corporate actions including splits, bonuses, and buybacks.
Check Tyche Industries stock events that may affect TYCHE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 3.00 /share | -3.79% | ||
| Dividend | ₹ 1.50 /share | 18.06% | ||
| Dividend | ₹ 1.00 /share | -14.43% | ||
| Dividend | ₹ 2.50 /share | -6.58% | ||
| Annual General Meeting | NA | 2.68% | ||
| Annual General Meeting | NA | 0.66% | ||
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -1.98% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 12.30% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -1.27% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -0.15% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 0.44% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -9.34% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 13.99% |
| 2023-08-22 | 2023-08-22 | Dividend | ₹ 2.00 /share | -4.90% |
Tyche Industries Competitors Screener - Peer Comparison
Screen TYCHE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 458,945 | 39.71 | 58,220 | 6.38% | 11,565 | 70.99 |
| Divis Laboratories | 182,045 | 69.89 | 10,560 | 8.73% | 2,520 | 60.09 |
| Torrent Pharmaceuticals | 163,222 | 75.43 | 13,886 | 20.34% | 2,138 | 72.77 |
| Cipla | 118,939 | 30.51 | 29,045 | 2.24% | 3,870 | 69.69 |
| Zydus Life Science | 115,506 | 22.41 | 26,720 | 13.65% | 5,242 | 68.21 |
| Dr Reddys Laboratories | 114,174 | 27.60 | 35,059 | 3.90% | 4,158 | 64.81 |
| Lupin | 113,924 | 21.14 | 27,488 | 19.98% | 5,345 | 73.07 |
| Mankind Pharma | 104,963 | 53.93 | 14,278 | 12.03% | 1,750 | 61.95 |
| Aurobindo Pharma | 91,750 | 26.86 | 33,385 | 3.21% | 3,376 | 64.92 |
| Laurus Labs | 82,555 | 93.55 | 6,868 | 22.01% | 890 | 68.43 |
Tyche Industries Company Announcements - News Screener
Screen TYCHE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-24 | Closure of Trading Window | - |
| 2026-05-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-29 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-28 | Re-Appointment Of Internal Auditor And Cost Auditor | - |
| 2026-05-28 | Corporate Action-Board approves Dividend | - |
| 2026-05-28 | Audited Financial Results For The Quarter And Financial Year Ended 31St March 2026 | - |
| 2026-05-28 | Board Meeting Outcome for Outcome Of Board Meeting Held On May 28 2026 | - |
| 2026-05-19 | Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2026 And Recommendation Of The Final Dividend For The FY 2025-26 | - |
| 2026-04-30 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-25 | Closure of Trading Window | - |
| 2026-03-24 | Intimation Regarding Receipt Of ANVISA Brazil GMP Certificate For The Companys Manufacturing Facility Located At Kakinada Andhra Pradesh. | - |
| 2026-03-20 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-20 | Disclosures Under Reg. 10(6) Of SEBI (SAST) Regulations 2011 | - |
| 2026-03-20 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-03-04 | Disclosures Under Reg. 10(5) In Respect Of Acquisition Under Reg. 10(1)(A) Of SEBI (SAST) Regulations 2011 | - |
| 2026-03-04 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-13 | Resubmission Of Auditors Limited Review Report On Unaudited Financial Results With UDIN Which Was Missed Due To The Non-Generation Of UDIN Owing To Technical Issue In ICAI Portal | - |
| 2026-02-12 | Un-Audited Financial Results For The 3Rd Quarter And Nine Months Ended 31St December 2025. | - |